As the SpaceX IPO continues to spark global market debate, Crowdfund Insider brings together fintech and investment commentators to assess what this listing could mean for public markets, innovation, and investor appetite. Sean Peche, Portfolio Manager at Ranmore Fund Management, draws a parallel to purchasing Pfizer shares in April of 1998. Bloomberg indicates the total return would have been a negative 26% over 28 years. Read more here: Fintech Observers Comment On SpaceX I

Emerging markets continue to evolve at remarkable speed — but finding the companies truly positioned for long‑term growth requires discipline, insight, and a deep understanding of structural change. This article explores how active stock selection, demographic trends, and the rise of digital ecosystems are reshaping opportunities across global emerging markets. It’s a thoughtful look at why quality, profitability, and strong management matter more than ever when identifying t

The asset‑management landscape is shifting faster than many expected. From technological disruption to evolving client expectations, the industry is being reshaped by a wave of catalysts that demand fresh thinking and bold adaptation. This insightful piece explores how leaders like Aubrey’s Andrew Pinner are navigating these changes — and why the future of asset management will belong to those who embrace innovation rather than resist it. A worthwhile read for anyone interest

Rob Brewis, director and investment manager of global emerging markets strategy at Aubrey Capital Management, explores how India's...

The Group of Boutique Asset Managers (GBAM), a global network of independent specialist asset managers is urging investment consultants,...